Correction to: Scientific Reports https://doi.org/10.1038/s41598-020-58527-0, published online 31 January 2020
The original version of this Article contained errors.
As a result of an error in the figure assembly, the panels of Figure 12 were positioned incorrectly.
The original Figure 12 and its accompanying legend appear below.
In addition, the Article contained a repeated error in the legends of Figure 8, Figure 11 and Figure 12, where the ‘HT-29’ cell line was incorrectly given as ‘MCF7’.
As a result, the legend of Figure 8:
“Rhodamine b labelled PCL-PEG-PCL Triblock (TB) and PLA-PCL-PEG-PCL-PLA pentablock (PB) nanoparticles uptake by MCF7 cells after different exposure times of 0.5, 1, 2, 3 and 24 h assessed by flow-cytometry.”
now reads:
“Rhodamine b labelled PCL-PEG-PCL Triblock (TB) and PLA-PCL-PEG-PCL-PLA pentablock (PB) nanoparticles uptake by HT-29 cells after different exposure times of 0.5, 1, 2, 3 and 24 h assessed by flow-cytometry.”
The legend of Figure 11:
“Annexin V and PI staining was used to identify viable cells (annexin V−, PI−), early apoptotic cells (annexin V+, PI−), late apoptotic (annexin V+, PI+) and necrotic cells (annexin V−, PI+). (A) The apoptotic effects of cells, determined by flow cytometry after 12 h in MCF7 cells for (a) untreated cells as a control, free auraptene (AUR) with AUR concentration of (b) 7.5 and (c) 15 µg/mL, (d) PCL-PEG-PCL (TB), auraptene-loaded PCL-PEG-PCL (TB-AUR) with AUR concentration of (e) 7.5 and (f) 15 µg/mL, (g) PLA-PCL-PEG-PCL-PLA (PB) nanoparticles, auraptene-loaded PLA-PCL-PEG-PCL-PLA (PB-AUR) nano-particles with AUR concentration of (h) 7.5 and (i) 15 µg.mL. (B) Quantitative results of apoptotic effects evaluated by Annexin V/FITC assay.”
now reads:
“Annexin V and PI staining was used to identify viable cells (annexin V−, PI−), early apoptotic cells (annexin V+, PI−), late apoptotic (annexin V+, PI+) and necrotic cells (annexin V−, PI+). (A) The apoptotic effects of cells, determined by flow cytometry after 12 h in HT-29 cells for (a) untreated cells as a control, free auraptene (AUR) with AUR concentration of (b) 7.5 and (c) 15 µg/mL, (d) PCL-PEG-PCL (TB), auraptene-loaded PCL-PEG-PCL (TB-AUR) with AUR concentration of (e) 7.5 and (f) 15 µg/mL, (g) PLA-PCL-PEG-PCL-PLA (PB) nanoparticles, auraptene-loaded PLA-PCL-PEG-PCL-PLA (PB-AUR) nano-particles with AUR concentration of (h) 7.5 and (i) 15 µg.mL. (B) Quantitative results of apoptotic effects evaluated by Annexin V/FITC assay.”
The legend of Figure 12:
“Microscopic images of DAPI stained MCF7 cells following 72 h of exposure to untreated cells as (a) control, free auraptene (AUR) with AUR concentration of (b) 7.5 and (c) 15 µg/mL, (d) PCL-PEG-PCL nanoparticles (TB), auraptene-loaded PCL-PEG-PCL nanoparticles (TB-AUR) with AUR concentration of (e) 7.5 and (f) 15 µg.mL−1, (g) PLA-PCL-PEG-PCL-PLA (PB) nanoparticles, auraptene-loaded PLA-PCL-PEG-PCL-PLA (PB-AUR) nanoparticles with AUR concentration of (h) 7.5 and, (i) 15 µg.mL−1.”
now reads:
“Microscopic images of DAPI stained HT-29 cells following 72 h of exposure to untreated cells as (a) control, free auraptene (AUR) with AUR concentration of (b) 7.5 and (c) 15 µg/mL, (d) PCL-PEG-PCL nanoparticles (TB), auraptene-loaded PCL-PEG-PCL nanoparticles (TB-AUR) with AUR concentration of (e) 7.5 and (f) 15 µg.mL−1, (g) PLA-PCL-PEG-PCL-PLA (PB) nanoparticles, auraptene-loaded PLA-PCL-PEG-PCL-PLA (PB-AUR) nanoparticles with AUR concentration of (h) 7.5 and, (i) 15 µg.mL−1.”
The original Article has been corrected.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Jalilzadeh, N., Samadi, N., Salehi, R. et al. Author Correction: Novel nano-vehicle for delivery and efficiency of anticancer auraptene against colon cancer cells. Sci Rep 14, 7873 (2024). https://doi.org/10.1038/s41598-024-56785-w
Published:
DOI: https://doi.org/10.1038/s41598-024-56785-w
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.